Tags

Type your tag names separated by a space and hit enter

[Indicators of glycated proteins in the diagnosis of diabetes. Use in populations with a high prevalence of hemoglobinopathies].
Ann Biol Clin (Paris). 1988; 46(9):719-21.AB

Abstract

The authors compare the relative validity of HbA1c and fructosamine as indices of long-term blood glucose levels in population with a common occurrence of haemoglobinopathies. HbA1c levels in patients with haemoglobinopathies do not reflect the glucidic status of patients when compared to HbA1c levels in reference population. Validity of the fructosamine assay allows its potential use as a mass screening test for diabetes in these populations (USA, Africa, Caribbean...).

Authors+Show Affiliations

Pileire B
Laboratoire de Biochimie, INSERM-SASD, Centre Hospitalier Régional et Universitaire, Pointe a Pitre, Guadeloupe.
Moutet JP
No affiliation info available
Bangou J
No affiliation info available
Ragoucy-Sengler CM
No affiliation info available

MeSH

Blood GlucoseDiabetes MellitusFructosamineGlycated HemoglobinGlycosylationHemoglobinopathiesHexosaminesHumansHyperglycemia

Pub Type(s)

Comparative Study
Journal Article
Research Support, Non-U.S. Gov't

Language

fre

PubMed ID

3223631

Citation

Pileire, B, et al. "[Indicators of Glycated Proteins in the Diagnosis of Diabetes. Use in Populations With a High Prevalence of Hemoglobinopathies]." Annales De Biologie Clinique, vol. 46, no. 9, 1988, pp. 719-21.
Pileire B, Moutet JP, Bangou J, et al. [Indicators of glycated proteins in the diagnosis of diabetes. Use in populations with a high prevalence of hemoglobinopathies]. Ann Biol Clin (Paris). 1988;46(9):719-21.
Pileire, B., Moutet, J. P., Bangou, J., & Ragoucy-Sengler, C. M. (1988). [Indicators of glycated proteins in the diagnosis of diabetes. Use in populations with a high prevalence of hemoglobinopathies]. Annales De Biologie Clinique, 46(9), 719-21.
Pileire B, et al. [Indicators of Glycated Proteins in the Diagnosis of Diabetes. Use in Populations With a High Prevalence of Hemoglobinopathies]. Ann Biol Clin (Paris). 1988;46(9):719-21. PubMed PMID: 3223631.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Indicators of glycated proteins in the diagnosis of diabetes. Use in populations with a high prevalence of hemoglobinopathies]. AU - Pileire,B, AU - Moutet,J P, AU - Bangou,J, AU - Ragoucy-Sengler,C M, PY - 1988/1/1/pubmed PY - 1988/1/1/medline PY - 1988/1/1/entrez SP - 719 EP - 21 JF - Annales de biologie clinique JO - Ann Biol Clin (Paris) VL - 46 IS - 9 N2 - The authors compare the relative validity of HbA1c and fructosamine as indices of long-term blood glucose levels in population with a common occurrence of haemoglobinopathies. HbA1c levels in patients with haemoglobinopathies do not reflect the glucidic status of patients when compared to HbA1c levels in reference population. Validity of the fructosamine assay allows its potential use as a mass screening test for diabetes in these populations (USA, Africa, Caribbean...). SN - 0003-3898 UR - https://www.unboundmedicine.com/medline/citation/3223631/[Indicators_of_glycated_proteins_in_the_diagnosis_of_diabetes__Use_in_populations_with_a_high_prevalence_of_hemoglobinopathies]_ DB - PRIME DP - Unbound Medicine ER -